| Role of OATP1B1 and OATP1B3 in drug-drug interactions mediated by tyrosine kinase inhibitors DA Garrison, Z Talebi, ED Eisenmann, A Sparreboom, SD Baker Pharmaceutics 12 (9), 856, 2020 | 32 | 2020 |
| TP-0903 is active in models of drug-resistant acute myeloid leukemia JY Jeon, DR Buelow, DA Garrison, M Niu, ED Eisenmann, KM Huang, ... JCI insight 5 (23), 2020 | 21 | 2020 |
| Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1 ME Uddin, DA Garrison, K Kim, Y Jin, ED Eisenmann, KM Huang, ... Frontiers in Pharmacology 12, 644342, 2021 | 16 | 2021 |
| Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3‐ITD AML DR Buelow, SB Pounds, YD Wang, L Shi, Y Li, D Finkelstein, S Shurtleff, ... Clinical and Translational Science 12 (6), 641-647, 2019 | 16 | 2019 |
| DNA methyltransferase inhibitor exposure–response: Challenges and opportunities AB Kagan, DA Garrison, NM Anders, JA Webster, SD Baker, ... Clinical and translational science 16 (8), 1309-1322, 2023 | 8 | 2023 |
| Interaction of antifungal drugs with CYP3A-and OATP1B-mediated venetoclax elimination ED Eisenmann, DA Garrison, Z Talebi, Y Jin, JA Silvaroli, JG Kim, ... Pharmaceutics 14 (4), 694, 2022 | 8 | 2022 |
| Intentional modulation of ibrutinib pharmacokinetics through CYP3A inhibition ED Eisenmann, Q Fu, EM Muhowski, Y Jin, ME Uddin, DA Garrison, ... Cancer research communications 1 (2), 79-89, 2021 | 8 | 2021 |
| MATE1 deficiency exacerbates dofetilide-induced proarrhythmia ME Uddin, ED Eisenmann, Y Li, KM Huang, DA Garrison, Z Talebi, ... International journal of molecular sciences 23 (15), 8607, 2022 | 6 | 2022 |
| Itraconazole-induced increases in gilteritinib exposure are mediated by CYP3A and OATP1B DA Garrison, Y Jin, Z Talebi, S Hu, A Sparreboom, SD Baker, ... Molecules 27 (20), 6815, 2022 | 4 | 2022 |
| Development, validation, and application of an LC-MS/MS method for the determination of the AXL/FLT3 inhibitor gilteritinib in mouse plasma DA Garrison, Y Jin, ME Uddin, A Sparreboom, SD Baker Journal of Chromatography B 1179, 122882, 2021 | 4 | 2021 |
| Interaction of the FLT3 inhibitor gilteritinib with xenobiotic uptake transporters D Garrison, Z Talebi, Y Jin, ME Uddin, A Gibson, A Sparreboom, S Baker The FASEB Journal 35, 2021 | 2 | 2021 |
| Modulation of CYP3A Activity to Increase the Oral Bioavailability of Ibrutinib ED Eisenmann, Q Fu, D Garrison, B Weber, S Hu, J Woyach, JC Byrd, ... The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
| Activity of TP‐0903 in FLT3 inhibitor resistant AML models JY Jeon, D Garrison, MZ Thomas, D Buelow, C Whatcott, S Warner, J Byrd, ... The FASEB Journal 33 (S1), 675.4-675.4, 2019 | 1 | 2019 |
| Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method Z Talebi, DA Garrison, ED Eisenmann, K Parmar, GI Shapiro, MA Rudek, ... Heliyon 9 (11), 2023 | | 2023 |
| Contribution of MATE1 to Dofetilide-Induced Proarrhythmia EM Uddin, ED Eisenmann, KM Huang, DA Garrison, Z Talebi, AA Gibson, ... International journal of molecular sciences 23, 2022 | | 2022 |
| Interaction of Gilteritinib, a novel FLT-3 Tyrosine Kinase Inhibitor, with Xenobiotic Uptake Transporters DA Garrison The Ohio State University, 2022 | | 2022 |
| Activity of the multikinase inhibitor TP‐0903 in RAS mutant acute myeloid leukemia JY Jeon, E Eisenmann, M Niu, D Garrison, D Buelow, MZ Thomas, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Upregulation of Stromal‐derived Factor‐1 by Hypoxia Requires Hypoxia‐Inducible Factor‐1α and Transforming Growth Factor‐1 JD Strickland, D Garrison, B Copple The FASEB Journal 32, 415.5-415.5, 2018 | | 2018 |
| Genomic Profiling Identifies Novel Mutations and Fusion Genes in Newly Diagnosed and Relapsed Pediatric FLT3-ITD-Positive AML DR Buelow, S Pounds, YD Wang, L Shi, Y Li, D Finkelstein, SA Shurtleff, ... Blood 128 (22), 2838, 2016 | | 2016 |
